|
铝酸镁,尖晶石
|
M333153-100g
|
≥99.9% metals basis, D1=1μm |
12068-51-8 |
100g
|
¥ 1436.9
|
现货 |
|
0 |
阿拉丁 |
|
铝酸镁,尖晶石
|
M333153-25g
|
≥99.9% metals basis, D1=1μm |
12068-51-8 |
25g
|
¥ 576.9
|
现货 |
|
0 |
阿拉丁 |
|
3-(甲基氨基)-1-苯基丙-1-酮盐酸盐
|
M303230-5g
|
≥97% |
2538-50-3 |
5g
|
¥ 2047.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-甲基-2-苯基-1,2-二氢吡唑-3-酮
|
M302686-500g
|
≥98% |
19735-89-8 |
500g
|
¥ 1837.9
|
现货 |
|
0 |
阿拉丁 |
|
甲氧西林钠
|
M302401-5mg
|
≥85% |
132-92-3 |
5mg
|
¥ 257.9
|
现货 |
|
0 |
阿拉丁 |
|
甲氧西林钠
|
M302401-100mg
|
≥85% |
132-92-3 |
100mg
|
¥ 2141.9
|
现货 |
|
0 |
阿拉丁 |
|
2-甲基-1,4-亚苯基双(4-((6-(丙烯酰氧基)己基)氧基)苯甲酸酯)
|
M302296-100g
|
≥97% |
125248-71-7 |
100g
|
¥ 1979.9
|
现货 |
|
0 |
阿拉丁 |
|
2-甲基-1,4-亚苯基双(4-((6-(丙烯酰氧基)己基)氧基)苯甲酸酯)
|
M302296-25g
|
≥97% |
125248-71-7 |
25g
|
¥ 549.9
|
现货 |
|
0 |
阿拉丁 |
|
1,3,5-三甲基-2,4,6-三(4-羧基苯基)苯
|
M302292-5g
|
≥98% |
1246562-60-6 |
5g
|
¥ 2502.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
甲氧虫酰肼
|
M299025-25g
|
≥97% |
161050-58-4 |
25g
|
¥ 4633.9
|
现货 |
|
0 |
阿拉丁 |
|
线粒体融合启动子M1
|
M287956-100mg
|
≥98%(HPLC) |
219315-22-7 |
100mg
|
¥ 1097.9
|
现货 |
|
0 |
阿拉丁 |
|
线粒体融合启动子M1
|
M287956-5mg
|
≥98%(HPLC) |
219315-22-7 |
5mg
|
¥ 146.9
|
现货 |
|
0 |
阿拉丁 |
|
四氯氧化钼(VI)
|
M283423-1g
|
≥97% |
13814-75-0 |
1g
|
¥ 772.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
四氯氧化钼(VI)
|
M283423-250mg
|
≥97% |
13814-75-0 |
250mg
|
¥ 308.9
|
现货 |
|
0 |
阿拉丁 |
|
1,2-双(4-氯苯)乙基-1,2-二胺
|
M281493-5g
|
≥98% |
74641-30-8 |
5g
|
¥ 1245.9
|
现货 |
|
0 |
阿拉丁 |
|
1,2-双(4-氯苯)乙基-1,2-二胺
|
M281493-1g
|
≥98% |
74641-30-8 |
1g
|
¥ 281.9
|
现货 |
|
0 |
阿拉丁 |
|
1,2-双(4-氯苯)乙基-1,2-二胺
|
M281493-250mg
|
≥98% |
74641-30-8 |
250mg
|
¥ 104.9
|
现货 |
|
0 |
阿拉丁 |
|
ME 0328,PARP-3抑制剂
|
M276516-100mg
|
Moligand™, ≥98% |
1445251-22-8 |
100mg
|
¥ 718.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
ME 0328,PARP-3抑制剂
|
M276516-50mg
|
Moligand™, ≥98% |
1445251-22-8 |
50mg
|
¥ 494.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
ME 0328,PARP-3抑制剂
|
M276516-10mg
|
Moligand™, ≥98% |
1445251-22-8 |
10mg
|
¥ 150.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Mertansine(DM1化合物)
|
M276427-5mg
|
≥98% |
139504-50-0 |
5mg
|
¥ 504.9
|
现货 |
|
0 |
阿拉丁 |
|
ML 141,非竞争性Cdc42 GTPase抑制剂
|
M275404-100mg
|
≥98% |
71203-35-5 |
100mg
|
¥ 6399.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
ML 141,非竞争性Cdc42 GTPase抑制剂
|
M275404-50mg
|
≥98% |
71203-35-5 |
50mg
|
¥ 3742.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
ML 141,非竞争性Cdc42 GTPase抑制剂
|
M275404-10mg
|
≥98% |
71203-35-5 |
10mg
|
¥ 813.9
|
期货,请咨询 |
|
0 |
阿拉丁 |